Rocket Pharmaceuticals Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.35

+0.19 (+6.01%)

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 11 55%

Hold 7 35%

Sell 2 10%

Price Target

Analyst Price Target +403.6% upside

Low Target $13.87

Average Target $16.87

High Target $23.44

Current Price $3.35

Current
$3.35

Target
$16.87

$13.87 $16.87 avg $23.44

Scenario Analysis

Bear Case

$13.87

314.0%

Low target

Base Case

$16.87

+403.6%

Avg target

Bull Case

$23.44

+599.7%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$5.45

-38.5% from high

52-Week Low

$2.40

+39.6% from low

Target vs 52W High

$16.87

+209.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%